• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

American Lung Association slams cigarette maker for inhaled medical therapy acquisition

July 20, 2021 By Sean Whooley

Philip Morris Vectura American Lung AssociationThe American Lung Association condemned the recently announced acquisition of Vectura by cigarette maker Philip Morris (NYSE:PM).

Earlier this month, Philip Morris announced that it agreed to acquire inhaled drug delivery technology developer Vectura for $1.2 billion.

In response to the acquisition, American Lung Association president & CEO Harold Wimmer and American Thoracic Society president Dr. Lynn Schnapp released a joint statement calling the purchase “the latest reprehensible choice from a company that has profited from addicting users to its deadly products.”

United Kingdom-based Vectura’s drug delivery solutions under development include 13 key inhaled and 11 non-inhaled products marketed by global pharmaceutical partners. The company also has a diverse portfolio of partnerships for drugs in clinical development and brought in net revenues of $245 million in 2020.

Philip Morris – a multinational cigarette and tobacco product manufacturer — claimed that Vectura’s pipeline can help it reach its goal of generating more than 50% of its total net revenue from smoke-free products by 2025, with the intent to generate at least $1 billion in net revenues by that point from its “Beyond Nicotine” products.

“We are deeply concerned that PMI will use the inhalation services technologies developed by Vectura to make their tobacco products more addictive,” Wimmer and Schnapp’s statement said. “We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes.”

The statement also noted that the acquisition creates a “complex entanglement of conflicts of interest” across the respiratory medicine supply chain, claiming a chance of undermining public confidence in essential medical products. Wimmer and Schnapp believe the acquisition is “not in the best interest of the public and lung disease patients, or even the medical drug and device industry.”

“The American Lung Association and American Thoracic Society are disappointed that the board of Vectura, a maker of essential medical products, has approved this sale,” the statement concluded. “We urge the shareholders of Vectura to reject the proposed sale. Failing shareholder action, we urge the British government to use its oversight authority to intervene and stop the sale.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Respiratory Tagged With: American Lung Association, American Thoracic Society, Philip Morris, Vectura

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS